Showing results (291-300 of 329) with videos related to
Sort By:
Pageof 33
Cancer|June 15, 1991
Chemotherapy with 5-fluorouracil (5-FU) and cisplatin or 5-FU, cisplatin, and vinblastine for advanced non-small cell lung cancer. A randomized phase II study of the cancer and leukemia group BF Richards, D J Perry, M Goutsou, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1984
Alternating combination chemotherapy for stages III and IV ovarian carcinomaJ A Young, A Johnson, J Kroener, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1992
Intensive combination chemotherapy, concurrent chest irradiation, and warfarin for the treatment of limited-disease small-cell lung cancer: a Cancer and Leukemia Group B pilot studyJ Aisner, M Goutsou, L H Maurer, et al.Cancer|April 29, 1998
Dihydro-5-azacytidine and cisplatin in the treatment of malignant mesothelioma: a phase II study by the Cancer and Leukemia Group BB L Samuels, J E Herndon, D C Harmon, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1993
AMOPLACE treatment of intermediate-grade and high-grade malignant lymphoma: a Cancer and Leukemia Group B studyB A Parker, M Santarelli, M R Green, et al.Psychotherapy and Psychosomatics|January 1, 1994
Quality of life in patients with limited small-cell carcinoma of the lung receiving chemotherapy with or without radiation therapy, for cancer and leukemia group BT A Ahles, P M Silberfarb, A C Rundle, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1994
Cisplatin, vinblastine, and hydrazine sulfate in advanced, non-small-cell lung cancer: a randomized placebo-controlled, double-blind phase III study of the Cancer and Leukemia Group BM P Kosty, S B Fleishman, J E Herndon, et al.Lung Cancer (Amsterdam, Netherlands)|March 8, 2000
Paclitaxel/ifosfamide or navelbine/ifosfamide chemotherapy for advanced non-small cell lung cancer: CALGB 9532M C Perry, D C Ihde, J E Herndon, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 17, 2001
Twenty-two years of phase III trials for patients with advanced non-small-cell lung cancer: sobering resultsO S Breathnach, B Freidlin, B Conley, et al.The EMBO Journal|January 1, 1991
Mammalian nuclei contain foci which are highly enriched in components of the pre-mRNA splicing machineryM Carmo-Fonseca, D Tollervey, R Pepperkok, et al.Pageof 33